DK433781A - Fremgangsmaade til fremstilling af n-(2-pyrimidinyl) piperazinylalkylazespiroalkadioner - Google Patents

Fremgangsmaade til fremstilling af n-(2-pyrimidinyl) piperazinylalkylazespiroalkadioner

Info

Publication number
DK433781A
DK433781A DK433781A DK433781A DK433781A DK 433781 A DK433781 A DK 433781A DK 433781 A DK433781 A DK 433781A DK 433781 A DK433781 A DK 433781A DK 433781 A DK433781 A DK 433781A
Authority
DK
Denmark
Prior art keywords
piperazinylalkylazespiroal
cadiations
pyrimidinyl
preparing
procedure
Prior art date
Application number
DK433781A
Other languages
English (en)
Other versions
DK148481C (da
DK148481B (da
Inventor
J C Simms
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22729338&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK433781(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of DK433781A publication Critical patent/DK433781A/da
Priority to DK85285A priority Critical patent/DK85285A/da
Publication of DK148481B publication Critical patent/DK148481B/da
Application granted granted Critical
Publication of DK148481C publication Critical patent/DK148481C/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/10—Spiro-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/10—Spiro-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK433781A 1980-10-16 1981-09-30 Azaspiro-kvarternaere ammoniumhalogenide og en fremgangsmaade, ved hvilken disse anvendes til fremstilling af n-(2-pyrimidinyl)-piperazinylalkylazaspiroalkandioner DK148481C (da)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DK85285A DK85285A (da) 1980-10-16 1985-02-25 Fremgangsmaade til fremstilling af azaspirokvaternaere ammoniumhalogenider

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/197,416 US4351939A (en) 1980-10-16 1980-10-16 Spiro-quaternary ammonium halides and N-(2-pyrimidinyl)piperazinylalkylazaspiroalkanedione process
US19741680 1980-10-16

Publications (3)

Publication Number Publication Date
DK433781A true DK433781A (da) 1982-04-17
DK148481B DK148481B (da) 1985-07-15
DK148481C DK148481C (da) 1985-12-16

Family

ID=22729338

Family Applications (1)

Application Number Title Priority Date Filing Date
DK433781A DK148481C (da) 1980-10-16 1981-09-30 Azaspiro-kvarternaere ammoniumhalogenide og en fremgangsmaade, ved hvilken disse anvendes til fremstilling af n-(2-pyrimidinyl)-piperazinylalkylazaspiroalkandioner

Country Status (33)

Country Link
US (1) US4351939A (da)
JP (2) JPS5724384A (da)
KR (2) KR870000321B1 (da)
AT (1) AT382153B (da)
AU (1) AU524822B2 (da)
BE (1) BE890509A (da)
CA (1) CA1175832A (da)
CH (1) CH647778A5 (da)
CY (1) CY1325A (da)
DE (1) DE3141256C2 (da)
DK (1) DK148481C (da)
ES (2) ES8206516A1 (da)
FI (1) FI75159C (da)
FR (1) FR2492383A1 (da)
GB (1) GB2085436B (da)
GR (1) GR74687B (da)
HK (1) HK35386A (da)
HU (2) HU185967B (da)
IE (1) IE51646B1 (da)
IL (1) IL64047A (da)
IT (1) IT1143244B (da)
KE (1) KE3596A (da)
LU (1) LU83657A1 (da)
MY (1) MY8600475A (da)
NL (2) NL179055C (da)
NZ (1) NZ196974A (da)
OA (1) OA06920A (da)
PT (1) PT73824B (da)
SE (2) SE439167B (da)
SG (1) SG97885G (da)
SU (1) SU1342420A3 (da)
YU (2) YU42565B (da)
ZA (1) ZA812759B (da)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT387221B (de) * 1980-09-08 1988-12-27 Bristol Myers Co Verfahren zur herstellung des neuen
US4507303A (en) * 1981-12-22 1985-03-26 Sumitomo Chemical Company, Limited Succinimide derivatives, compositions and method of use
US4452799A (en) * 1981-12-23 1984-06-05 Mead Johnson & Company Benzisothiazole and benzisoxazole piperazine derivatives
JPS5945380U (ja) * 1982-09-20 1984-03-26 いすゞ自動車株式会社 車両用帯状体の固定装置
US5066783A (en) * 1986-05-20 1991-11-19 Cohen Eric A Antiviral peptides and means for treating herpes infections
US4810789A (en) * 1987-08-28 1989-03-07 Bristol-Myers Company Process for buspirone hydrochloride polymorphic crystalline form conversion
US5015646A (en) * 1987-08-28 1991-05-14 Bristol-Myers Squibb Co. Pharmaceutically useful polymorphic modification of buspirone
US5631017A (en) * 1993-03-26 1997-05-20 Beth Israel Deaconess Medical Center, Inc. Topical application of buspirone for treatment of pathological conditions associated with immune responses
US5484788A (en) * 1993-03-26 1996-01-16 Beth Israel Hospital Association Buspirone as a systemic immunosuppressant
FR2705098B1 (fr) * 1993-05-10 1995-08-04 Esteve Labor Dr Procédé de préparation de 2-{4-[4-(chloro-1-pyrazolyl)butyl]1-pipérazinyl}pyrimidine (Lesopitron) .
US5521313A (en) * 1994-05-05 1996-05-28 Bristol-Myers Squibb Company Process for preparing certain azapirones
CA2146593A1 (en) * 1994-05-05 1995-11-06 Jack Melton Large-scale process for azapirone synthesis
US5637314A (en) * 1995-06-07 1997-06-10 Beth Israel Deaconess Medical Center, Inc. Topical and systemic application of buspirone or derivatives thereof for treating atopic dermatitis
TW200302728A (en) * 2002-02-01 2003-08-16 Novartis Ag Substituted amines as IgE inhibitors
DE602006021437D1 (de) * 2005-08-30 2011-06-01 Honeywell Int Inc Verfahren zur synthese von quaternären ammonium-spirosystemen
CN101089000B (zh) * 2006-06-16 2011-01-05 北京大学 螺环哌嗪季铵盐类化合物及其制备方法和应用
CN101362751B (zh) * 2007-08-10 2011-05-11 成都科瑞德医药投资有限责任公司 枸橼酸坦度螺酮及其制备方法、制剂和质量控制方法
WO2011136384A1 (en) * 2010-04-26 2011-11-03 Dainippon Sumitomo Pharma Co., Ltd. A process of a quaternary ammonium salt using phosphate
EP2563790B1 (en) * 2010-04-26 2016-09-14 Sumitomo Dainippon Pharma Co., Ltd. A process of a quaternary ammonium salt
IT201900000657A1 (it) 2019-01-16 2020-07-16 Procos Spa Processo per la sintesi di gepirone

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB948730A (en) * 1959-04-08 1964-02-05 Wellcome Found Substituted cyclopropanes and related compounds
US3968216A (en) * 1969-10-29 1976-07-06 Smith Kline & French Laboratories Limited Method of inhibiting histamine activity with guanidine compounds
BE759371A (fr) * 1969-11-24 1971-05-24 Bristol Myers Co Azaspirodecanediones heterocycliques et procedes pour leur preparation

Also Published As

Publication number Publication date
ZA812759B (en) 1982-05-26
ATA444681A (de) 1986-06-15
IT1143244B (it) 1986-10-22
KE3596A (en) 1986-02-07
HU187999B (en) 1986-03-28
IT8149476A0 (it) 1981-10-13
MY8600475A (en) 1986-12-31
IE812420L (en) 1982-04-16
NL8104660A (nl) 1982-05-17
GR74687B (da) 1984-07-03
DE3141256A1 (de) 1982-08-19
IL64047A (en) 1984-12-31
SU1342420A3 (ru) 1987-09-30
PT73824A (en) 1981-11-01
SE439167B (sv) 1985-06-03
DE3141256C2 (de) 1986-06-05
JPS6153353B2 (da) 1986-11-17
JPS5724384A (en) 1982-02-08
FI75159C (fi) 1988-05-09
ES501994A0 (es) 1982-08-16
CY1325A (en) 1986-06-27
NZ196974A (en) 1983-05-31
DK148481C (da) 1985-12-16
YU136083A (en) 1986-02-28
SE8600174L (sv) 1986-01-15
NL179055C (nl) 1986-07-01
NL179055B (nl) 1986-02-03
KR870000321B1 (en) 1987-02-27
HK35386A (en) 1986-05-30
YU110381A (en) 1983-12-31
YU43316B (en) 1989-06-30
AT382153B (de) 1987-01-26
OA06920A (fr) 1983-05-31
JPS61178983A (ja) 1986-08-11
BE890509A (fr) 1982-03-25
CH647778A5 (de) 1985-02-15
IE51646B1 (en) 1987-01-21
KR890000465B1 (ko) 1989-03-18
KR830007659A (ko) 1983-11-04
SE447257B (sv) 1986-11-03
ES8304967A1 (es) 1983-03-16
SE8106060L (sv) 1982-04-17
GB2085436A (en) 1982-04-28
LU83657A1 (fr) 1982-04-14
HU185967B (en) 1985-04-28
FI75159B (fi) 1988-01-29
US4351939A (en) 1982-09-28
FR2492383B1 (da) 1985-01-25
JPS634828B2 (da) 1988-02-01
AU524822B2 (en) 1982-10-07
SG97885G (en) 1986-07-25
CA1175832A (en) 1984-10-09
FR2492383A1 (fr) 1982-04-23
ES8206516A1 (es) 1982-08-16
AU7029281A (en) 1982-04-22
IL64047A0 (en) 1982-01-31
NL8501430A (nl) 1985-09-02
FI813178L (fi) 1982-04-17
SE8600174D0 (sv) 1986-01-15
PT73824B (en) 1983-10-31
YU42565B (en) 1988-10-31
DK148481B (da) 1985-07-15
GB2085436B (en) 1984-01-18
ES511079A0 (es) 1983-03-16

Similar Documents

Publication Publication Date Title
DK350083D0 (da) Fremgangsmade til fremstilling af phenylethanolaminer
DK525481A (da) Fremgangsmaade til fremstilling af pyrimidoner
DK433781A (da) Fremgangsmaade til fremstilling af n-(2-pyrimidinyl) piperazinylalkylazespiroalkadioner
DK357081A (da) Fremgangsmaade til fremstilling af heterocycliske forbindelser
DK79882A (da) Fremgangsmaade til fremstilling af substituerede n-(4-indolyl-piperidino-alkyl)-benzimidazoloner
DK299483A (da) Fremgangsmaade til fremstilling af n-phosphonomethylglycin
DK457880A (da) Fremgangsmaade til fremstilling af 3-phenoxybenzaldehyder
DK489381A (da) Fremgangsmaade til fremstilling af aminopropoxyphenylderivater
DK501781A (da) Fremgangsmaade til fremstilling af 2-oxoazetidin-derivater
DK107181A (da) Fremgangsmaade til fremstilling af 1-(4-arylcyclohexyl)-piperidinderivater
DK283083D0 (da) Fremgangsmade til fremstilling af n-phosphonomethylglycin
DK553582A (da) Fremgangsmaade til fremstilling af naphthoxyalkylaminer
DK372081A (da) Fremgangsmaade til fremstilling af fluorerede pentendiaminderivater
DK451883D0 (da) Fremgangsmade til fremstilling af 4-methyl-5-alkylthiometyl-imidazoler
DK252981A (da) Fremgangsmaade til fremstilling af pyrimidinderivater
DK529181A (da) Fremgangsmaade til fremstilling af substituerede benzamider
DK226881A (da) Fremgangsmaade til fremstilling af 3-picolin
DK166581A (da) Fremgangsmaade til fremstilling af peptider
DK231581A (da) Fremgangsmaade til fremstilling af phenoxyaminopropanolderivater
DK371981A (da) Fremgangsmaade til fremstilling af aminoacetonitrilderivater
DK361983A (da) Fremgangsmaade til fremstilling af meldroejealkaloider
DK394783A (da) Fremgangsmaade til fremstilling af n-phosphonomethylglycin
DK399783D0 (da) Fremgangsmade til fremstilling af substituerede 1-puridyloxy-3-indolylalkylamino-2-propanoler
DK411881A (da) Fremgangsmaade til fremstilling af 1-oxa-beta-lactamantibiotika
DK380981A (da) Fremgangsmaade til fremstilling af benzoquinoliziner